[email protected]
CDI - Contrive Datum Insights
Healthcare Services

Home Infusion Therapy MarketSize, Share & Industry Analysis, 2026-2034By Therapy TypeBy ProductBy Service TypeBy Route of AdministrationBy IndicationBy Provider TypeBy Patient Age GroupBy Payer TypeBy Care SettingBy Duration of Therapy

Full title & scope — all 10 axes with their segments

Home Infusion Therapy Market Size, Share & Industry Analysis, By Therapy Type (Anti-Infective Therapy, Parenteral Nutrition, Enteral Nutrition, Immunoglobulin Therapy, Chemotherapy, Pain Management, Hydration Therapy, Inotropic and Cardiac Therapy, Specialty Biologics and Rare Disease Therapies), By Product (Infusion Pumps, IV Sets and Administration Sets, IV Catheters and Access Devices, IV Bags and Containers, Needleless Connectors and Accessories), By Service Type (Pharmacy Compounding and Dispensing, Skilled Nursing and Clinical Services, Equipment Rental and Supply, Patient Training and Care Coordination, Remote Patient Monitoring and Telepharmacy), By Route of Administration (Intravenous, Subcutaneous, Enteral, Epidural and Intrathecal, Intramuscular), By Indication (Infectious Diseases, Cancer, Primary and Secondary Immunodeficiency, Gastrointestinal Disorders and Short Bowel Syndrome, Neurological and Autoimmune Disorders, Hemophilia and Bleeding Disorders, Cardiovascular Disorders, Diabetes, Chronic Pain), By Provider Type (Independent Home Infusion Pharmacies, Hospital-Based Infusion Providers, Payer-Owned Infusion Providers, Specialty Pharmacy-Affiliated Providers, Home Health Agency-Based Providers), By Patient Age Group (Pediatric, Adult, Geriatric), By Payer Type (Medicare, Medicaid and Government Programs, Commercial Insurance, Out-of-Pocket and Self-Pay), By Care Setting (Patient Home, Ambulatory Infusion Suites, Assisted Living Facilities, Skilled Nursing Facilities), By Duration of Therapy (Short-Term (Acute) Therapy, Long-Term (Chronic) Therapy, Intermittent and Episodic Therapy), and Regional Forecast, 2026-2034

Last Updated: Nov 18, 2026Format: PDFReport ID: CDI-248901
TOC

Full table of contents for the published report, chapter by chapter.

Full chapter-and-section structure of the report. Segment, region, and company breakdowns are listed as scope. The underlying figures are in the sample and full report.

Table of Contents+
Chapter 1.Executive Summary
1.1Strategic Imperatives
1.2Definition
1.3Home Infusion Therapy Comparison By Segments
Chapter 2.Premium Insights
2.1Top 3 Trends to Watch
2.2Top 3 Strategies Followed by Major Players
2.3Top 3 Predictions by Contrive Datum Insights
2.4Top Investment Pockets
2.4.1Market Attractiveness Analysis, By Therapy Type
2.4.2Market Attractiveness Analysis, By Product
2.4.3Market Attractiveness Analysis, By Service Type
2.4.4Market Attractiveness Analysis, By Route of Administration
2.4.5Market Attractiveness Analysis, By Indication
2.4.6Market Attractiveness Analysis, By Provider Type
2.4.7Market Attractiveness Analysis, By Patient Age Group
2.4.8Market Attractiveness Analysis, By Payer Type
2.4.9Market Attractiveness Analysis, By Care Setting
2.4.10Market Attractiveness Analysis, By Duration of Therapy
2.5Key Market Participants — Intensity Mapping
2.6Insights From Primary Respondents
Chapter 3.Market Definition
Chapter 4.Research Methodology
4.1Research Approach
4.1.1Research Programs / Design
4.1.2Market Size Estimation
4.2Data Sources
4.2.1Secondary Sources
4.2.1.1Preliminary Data Mining
4.2.2Primary Sources
4.2.2.1Statistical Model
4.2.2.2Data Triangulation
4.2.2.3Research Objective
4.3Flow Of Methodology
4.4Top-Down / Bottom-Up Approach
Chapter 5.Strategic Imperatives & Market Outlook
Chapter 6.Go-to-Market (GTM) Strategies
6.1Market Focus & Value Proposition
6.1.1Target Customers, Priority Markets, and Core Value Proposition
6.1.2Product Differentiation and Positioning Logic
6.2Commercial Model & Pricing Strategy
6.2.1Pricing Approach and Value Capture
6.2.2Contracting, Bundling, and Monetization Framework
6.3Channels, Sales & Partnerships
6.3.1Direct and Indirect Channel Strategy
6.3.2Sales Execution Model and Strategic Partnerships
6.4Marketing, Launch & Execution Roadmap
6.4.1Marketing and Demand Generation Approach
6.4.2Launch Sequencing and Rollout Plan
6.5Operational Readiness & Governance KPIs
6.5.1Supply Chain and Operational Preparedness
6.5.2Regulatory Considerations, Risks, and Performance Tracking
Chapter 7.Market Trends, Strategy & Dynamics
7.1Trends Overview
7.2Strategic Overview
7.3Market Drivers
7.4Market Restraints
7.5Market Opportunities
7.6Market Challenges
7.7Impact Analysis of Market Dynamics
Chapter 8.Porter's Five Forces
8.1Bargaining Power of Suppliers
8.2Bargaining Power of Buyers
8.3Threat of New Entrants
8.4Threat of Substitutes
8.5Competitive Rivalry
Chapter 9.PESTEL Analysis
9.1Political
9.2Economic
9.3Social
9.4Technological
9.5Environmental
9.6Legal
Chapter 10.Value Chain Analysis
Chapter 11.Supply Chain Analysis
Chapter 12.Macro-Economic Factors
12.1Macro-Economic Factors Overview
12.2Forecast Factors — Relevance and Impact
Chapter 13.Market Cost Analysis
13.1Key Raw Materials Analysis
13.1.1Key Raw Materials
13.1.2Price Trend of Key Raw Materials
13.1.3Key Suppliers of Raw Materials
13.1.4Market Concentration Rate of Raw Materials
13.1.5Raw Materials
13.1.6Labor Cost
Chapter 14.Market Supply-Side Analysis
14.1Raw Materials
14.2Price Trends
14.3Industry Chain
14.4Raw Materials Sourcing
14.5Raw Materials Sources of Major Manufacturers
14.6Downstream Buyers
Chapter 15.Global Home Infusion Therapy Market Size & Projections, 2020–2034, Revenue (USD Billion)
15.1Global Home Infusion Therapy Market Size — Total
15.2Market Size, by Segment (By Therapy Type, By Product, By Service Type, By Route of Administration, By Indication, By Provider Type, By Patient Age Group, By Payer Type, By Care Setting, By Duration of Therapy)
Chapter 16.Global Home Infusion Therapy Market Overview, By Therapy Type, 2020–2034, Revenue (USD Billion)
16.1Introduction
16.2Global Home Infusion Therapy Market Size, By Therapy Type, 2020–2034, Revenue (USD Billion)
16.3Global Home Infusion Therapy Market Share, By Therapy Type (%)
16.3.1Anti-Infective Therapy
16.3.1.1Market Size, By Anti-Infective Therapy, 2020–2034, Revenue (USD Billion)
16.3.1.2Anti-Infective Therapy Size and Projections, By Product, 2020–2034, Revenue (USD Billion)
16.3.1.3Anti-Infective Therapy Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
16.3.1.4Anti-Infective Therapy Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
16.3.1.5Anti-Infective Therapy Size and Projections, By Indication, 2020–2034, Revenue (USD Billion)
16.3.1.6Anti-Infective Therapy Size and Projections, By Provider Type, 2020–2034, Revenue (USD Billion)
16.3.1.7Anti-Infective Therapy Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
16.3.1.8Anti-Infective Therapy Size and Projections, By Payer Type, 2020–2034, Revenue (USD Billion)
16.3.1.9Anti-Infective Therapy Size and Projections, By Care Setting, 2020–2034, Revenue (USD Billion)
16.3.1.10Anti-Infective Therapy Size and Projections, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
16.3.2Parenteral Nutrition
16.3.3Enteral Nutrition
16.3.4Immunoglobulin Therapy
16.3.5Chemotherapy
16.3.6Pain Management
16.3.7Hydration Therapy
16.3.8Inotropic and Cardiac Therapy
16.3.9Specialty Biologics and Rare Disease Therapies
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 16.3.1 (Anti-Infective Therapy).
Chapter 17.Global Home Infusion Therapy Market Overview, By Product, 2020–2034, Revenue (USD Billion)
17.1Introduction
17.2Global Home Infusion Therapy Market Size, By Product, 2020–2034, Revenue (USD Billion)
17.3Global Home Infusion Therapy Market Share, By Product (%)
17.3.1Infusion Pumps
17.3.1.1Market Size, By Infusion Pumps, 2020–2034, Revenue (USD Billion)
17.3.1.2Infusion Pumps Size and Projections, By Therapy Type, 2020–2034, Revenue (USD Billion)
17.3.1.3Infusion Pumps Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
17.3.1.4Infusion Pumps Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
17.3.1.5Infusion Pumps Size and Projections, By Indication, 2020–2034, Revenue (USD Billion)
17.3.1.6Infusion Pumps Size and Projections, By Provider Type, 2020–2034, Revenue (USD Billion)
17.3.1.7Infusion Pumps Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
17.3.1.8Infusion Pumps Size and Projections, By Payer Type, 2020–2034, Revenue (USD Billion)
17.3.1.9Infusion Pumps Size and Projections, By Care Setting, 2020–2034, Revenue (USD Billion)
17.3.1.10Infusion Pumps Size and Projections, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
17.3.2IV Sets and Administration Sets
17.3.3IV Catheters and Access Devices
17.3.4IV Bags and Containers
17.3.5Needleless Connectors and Accessories
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 17.3.1 (Infusion Pumps).
Chapter 18.Global Home Infusion Therapy Market Overview, By Service Type, 2020–2034, Revenue (USD Billion)
18.1Introduction
18.2Global Home Infusion Therapy Market Size, By Service Type, 2020–2034, Revenue (USD Billion)
18.3Global Home Infusion Therapy Market Share, By Service Type (%)
18.3.1Pharmacy Compounding and Dispensing
18.3.1.1Market Size, By Pharmacy Compounding and Dispensing, 2020–2034, Revenue (USD Billion)
18.3.1.2Pharmacy Compounding and Dispensing Size and Projections, By Therapy Type, 2020–2034, Revenue (USD Billion)
18.3.1.3Pharmacy Compounding and Dispensing Size and Projections, By Product, 2020–2034, Revenue (USD Billion)
18.3.1.4Pharmacy Compounding and Dispensing Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
18.3.1.5Pharmacy Compounding and Dispensing Size and Projections, By Indication, 2020–2034, Revenue (USD Billion)
18.3.1.6Pharmacy Compounding and Dispensing Size and Projections, By Provider Type, 2020–2034, Revenue (USD Billion)
18.3.1.7Pharmacy Compounding and Dispensing Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
18.3.1.8Pharmacy Compounding and Dispensing Size and Projections, By Payer Type, 2020–2034, Revenue (USD Billion)
18.3.1.9Pharmacy Compounding and Dispensing Size and Projections, By Care Setting, 2020–2034, Revenue (USD Billion)
18.3.1.10Pharmacy Compounding and Dispensing Size and Projections, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
18.3.2Skilled Nursing and Clinical Services
18.3.3Equipment Rental and Supply
18.3.4Patient Training and Care Coordination
18.3.5Remote Patient Monitoring and Telepharmacy
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 18.3.1 (Pharmacy Compounding and Dispensing).
Chapter 19.Global Home Infusion Therapy Market Overview, By Route of Administration, 2020–2034, Revenue (USD Billion)
19.1Introduction
19.2Global Home Infusion Therapy Market Size, By Route of Administration, 2020–2034, Revenue (USD Billion)
19.3Global Home Infusion Therapy Market Share, By Route of Administration (%)
19.3.1Intravenous
19.3.1.1Market Size, By Intravenous, 2020–2034, Revenue (USD Billion)
19.3.1.2Intravenous Size and Projections, By Therapy Type, 2020–2034, Revenue (USD Billion)
19.3.1.3Intravenous Size and Projections, By Product, 2020–2034, Revenue (USD Billion)
19.3.1.4Intravenous Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
19.3.1.5Intravenous Size and Projections, By Indication, 2020–2034, Revenue (USD Billion)
19.3.1.6Intravenous Size and Projections, By Provider Type, 2020–2034, Revenue (USD Billion)
19.3.1.7Intravenous Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
19.3.1.8Intravenous Size and Projections, By Payer Type, 2020–2034, Revenue (USD Billion)
19.3.1.9Intravenous Size and Projections, By Care Setting, 2020–2034, Revenue (USD Billion)
19.3.1.10Intravenous Size and Projections, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
19.3.2Subcutaneous
19.3.3Enteral
19.3.4Epidural and Intrathecal
19.3.5Intramuscular
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 19.3.1 (Intravenous).
Chapter 20.Global Home Infusion Therapy Market Overview, By Indication, 2020–2034, Revenue (USD Billion)
20.1Introduction
20.2Global Home Infusion Therapy Market Size, By Indication, 2020–2034, Revenue (USD Billion)
20.3Global Home Infusion Therapy Market Share, By Indication (%)
20.3.1Infectious Diseases
20.3.1.1Market Size, By Infectious Diseases, 2020–2034, Revenue (USD Billion)
20.3.1.2Infectious Diseases Size and Projections, By Therapy Type, 2020–2034, Revenue (USD Billion)
20.3.1.3Infectious Diseases Size and Projections, By Product, 2020–2034, Revenue (USD Billion)
20.3.1.4Infectious Diseases Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
20.3.1.5Infectious Diseases Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
20.3.1.6Infectious Diseases Size and Projections, By Provider Type, 2020–2034, Revenue (USD Billion)
20.3.1.7Infectious Diseases Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
20.3.1.8Infectious Diseases Size and Projections, By Payer Type, 2020–2034, Revenue (USD Billion)
20.3.1.9Infectious Diseases Size and Projections, By Care Setting, 2020–2034, Revenue (USD Billion)
20.3.1.10Infectious Diseases Size and Projections, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
20.3.2Cancer
20.3.3Primary and Secondary Immunodeficiency
20.3.4Gastrointestinal Disorders and Short Bowel Syndrome
20.3.5Neurological and Autoimmune Disorders
20.3.6Hemophilia and Bleeding Disorders
20.3.7Cardiovascular Disorders
20.3.8Diabetes
20.3.9Chronic Pain
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 20.3.1 (Infectious Diseases).
Chapter 21.Global Home Infusion Therapy Market Overview, By Provider Type, 2020–2034, Revenue (USD Billion)
21.1Introduction
21.2Global Home Infusion Therapy Market Size, By Provider Type, 2020–2034, Revenue (USD Billion)
21.3Global Home Infusion Therapy Market Share, By Provider Type (%)
21.3.1Independent Home Infusion Pharmacies
21.3.1.1Market Size, By Independent Home Infusion Pharmacies, 2020–2034, Revenue (USD Billion)
21.3.1.2Independent Home Infusion Pharmacies Size and Projections, By Therapy Type, 2020–2034, Revenue (USD Billion)
21.3.1.3Independent Home Infusion Pharmacies Size and Projections, By Product, 2020–2034, Revenue (USD Billion)
21.3.1.4Independent Home Infusion Pharmacies Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
21.3.1.5Independent Home Infusion Pharmacies Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
21.3.1.6Independent Home Infusion Pharmacies Size and Projections, By Indication, 2020–2034, Revenue (USD Billion)
21.3.1.7Independent Home Infusion Pharmacies Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
21.3.1.8Independent Home Infusion Pharmacies Size and Projections, By Payer Type, 2020–2034, Revenue (USD Billion)
21.3.1.9Independent Home Infusion Pharmacies Size and Projections, By Care Setting, 2020–2034, Revenue (USD Billion)
21.3.1.10Independent Home Infusion Pharmacies Size and Projections, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
21.3.2Hospital-Based Infusion Providers
21.3.3Payer-Owned Infusion Providers
21.3.4Specialty Pharmacy-Affiliated Providers
21.3.5Home Health Agency-Based Providers
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 21.3.1 (Independent Home Infusion Pharmacies).
Chapter 22.Global Home Infusion Therapy Market Overview, By Patient Age Group, 2020–2034, Revenue (USD Billion)
22.1Introduction
22.2Global Home Infusion Therapy Market Size, By Patient Age Group, 2020–2034, Revenue (USD Billion)
22.3Global Home Infusion Therapy Market Share, By Patient Age Group (%)
22.3.1Pediatric
22.3.1.1Market Size, By Pediatric, 2020–2034, Revenue (USD Billion)
22.3.1.2Pediatric Size and Projections, By Therapy Type, 2020–2034, Revenue (USD Billion)
22.3.1.3Pediatric Size and Projections, By Product, 2020–2034, Revenue (USD Billion)
22.3.1.4Pediatric Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
22.3.1.5Pediatric Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
22.3.1.6Pediatric Size and Projections, By Indication, 2020–2034, Revenue (USD Billion)
22.3.1.7Pediatric Size and Projections, By Provider Type, 2020–2034, Revenue (USD Billion)
22.3.1.8Pediatric Size and Projections, By Payer Type, 2020–2034, Revenue (USD Billion)
22.3.1.9Pediatric Size and Projections, By Care Setting, 2020–2034, Revenue (USD Billion)
22.3.1.10Pediatric Size and Projections, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
22.3.2Adult
22.3.3Geriatric
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 22.3.1 (Pediatric).
Chapter 23.Global Home Infusion Therapy Market Overview, By Payer Type, 2020–2034, Revenue (USD Billion)
23.1Introduction
23.2Global Home Infusion Therapy Market Size, By Payer Type, 2020–2034, Revenue (USD Billion)
23.3Global Home Infusion Therapy Market Share, By Payer Type (%)
23.3.1Medicare
23.3.1.1Market Size, By Medicare, 2020–2034, Revenue (USD Billion)
23.3.1.2Medicare Size and Projections, By Therapy Type, 2020–2034, Revenue (USD Billion)
23.3.1.3Medicare Size and Projections, By Product, 2020–2034, Revenue (USD Billion)
23.3.1.4Medicare Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
23.3.1.5Medicare Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
23.3.1.6Medicare Size and Projections, By Indication, 2020–2034, Revenue (USD Billion)
23.3.1.7Medicare Size and Projections, By Provider Type, 2020–2034, Revenue (USD Billion)
23.3.1.8Medicare Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
23.3.1.9Medicare Size and Projections, By Care Setting, 2020–2034, Revenue (USD Billion)
23.3.1.10Medicare Size and Projections, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
23.3.2Medicaid and Government Programs
23.3.3Commercial Insurance
23.3.4Out-of-Pocket and Self-Pay
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 23.3.1 (Medicare).
Chapter 24.Global Home Infusion Therapy Market Overview, By Care Setting, 2020–2034, Revenue (USD Billion)
24.1Introduction
24.2Global Home Infusion Therapy Market Size, By Care Setting, 2020–2034, Revenue (USD Billion)
24.3Global Home Infusion Therapy Market Share, By Care Setting (%)
24.3.1Patient Home
24.3.1.1Market Size, By Patient Home, 2020–2034, Revenue (USD Billion)
24.3.1.2Patient Home Size and Projections, By Therapy Type, 2020–2034, Revenue (USD Billion)
24.3.1.3Patient Home Size and Projections, By Product, 2020–2034, Revenue (USD Billion)
24.3.1.4Patient Home Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
24.3.1.5Patient Home Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
24.3.1.6Patient Home Size and Projections, By Indication, 2020–2034, Revenue (USD Billion)
24.3.1.7Patient Home Size and Projections, By Provider Type, 2020–2034, Revenue (USD Billion)
24.3.1.8Patient Home Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
24.3.1.9Patient Home Size and Projections, By Payer Type, 2020–2034, Revenue (USD Billion)
24.3.1.10Patient Home Size and Projections, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
24.3.2Ambulatory Infusion Suites
24.3.3Assisted Living Facilities
24.3.4Skilled Nursing Facilities
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 24.3.1 (Patient Home).
Chapter 25.Global Home Infusion Therapy Market Overview, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
25.1Introduction
25.2Global Home Infusion Therapy Market Size, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
25.3Global Home Infusion Therapy Market Share, By Duration of Therapy (%)
25.3.1Short-Term (Acute) Therapy
25.3.1.1Market Size, By Short-Term (Acute) Therapy, 2020–2034, Revenue (USD Billion)
25.3.1.2Short-Term (Acute) Therapy Size and Projections, By Therapy Type, 2020–2034, Revenue (USD Billion)
25.3.1.3Short-Term (Acute) Therapy Size and Projections, By Product, 2020–2034, Revenue (USD Billion)
25.3.1.4Short-Term (Acute) Therapy Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
25.3.1.5Short-Term (Acute) Therapy Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
25.3.1.6Short-Term (Acute) Therapy Size and Projections, By Indication, 2020–2034, Revenue (USD Billion)
25.3.1.7Short-Term (Acute) Therapy Size and Projections, By Provider Type, 2020–2034, Revenue (USD Billion)
25.3.1.8Short-Term (Acute) Therapy Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
25.3.1.9Short-Term (Acute) Therapy Size and Projections, By Payer Type, 2020–2034, Revenue (USD Billion)
25.3.1.10Short-Term (Acute) Therapy Size and Projections, By Care Setting, 2020–2034, Revenue (USD Billion)
25.3.2Long-Term (Chronic) Therapy
25.3.3Intermittent and Episodic Therapy
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 25.3.1 (Short-Term (Acute) Therapy).
Chapter 26.Global Home Infusion Therapy Market Size — Segment Comparison
Chapter 27.Global Home Infusion Therapy Geography Overview, 2020–2034, Revenue (USD Billion)
27.1Revenue, By Geography, 2020–2034, Revenue (USD Billion)
27.2Share, By Geography, 2020–2034 (%)
27.3Share, By Geography Analysis, 2025, Market Share and CAGR
27.4Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Chapter 28.North America Home Infusion Therapy Market Deep-Dive, 2020–2034, Revenue (USD Billion)
28.1Overview, 2020–2034
28.2Size and Projections, 2020–2034, Revenue (USD Billion)
28.2.1By Therapy Type, 2020–2034
28.2.2By Product, 2020–2034
28.2.3By Service Type, 2020–2034
28.2.4By Route of Administration, 2020–2034
28.2.5By Indication, 2020–2034
28.2.6By Provider Type, 2020–2034
28.2.7By Patient Age Group, 2020–2034
28.2.8By Payer Type, 2020–2034
28.2.9By Care Setting, 2020–2034
28.2.10By Duration of Therapy, 2020–2034
28.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
28.3.1US
28.3.1.1US — Key Country Dynamics
28.3.1.2US — Regulatory Framework
28.3.1.3US — Competitive Scenario
28.3.1.4US — Market Overview, 2020–2034, Revenue (USD Billion)
28.3.1.5US — Market Size and Projections, 2020–2034, Revenue (USD Billion)
28.3.1.6US Market Overview, By Therapy Type, 2020–2034, Revenue (USD Billion)
28.3.1.7US Market Overview, By Product, 2020–2034, Revenue (USD Billion)
28.3.1.8US Market Overview, By Service Type, 2020–2034, Revenue (USD Billion)
28.3.1.9US Market Overview, By Route of Administration, 2020–2034, Revenue (USD Billion)
28.3.1.10US Market Overview, By Indication, 2020–2034, Revenue (USD Billion)
28.3.1.11US Market Overview, By Provider Type, 2020–2034, Revenue (USD Billion)
28.3.1.12US Market Overview, By Patient Age Group, 2020–2034, Revenue (USD Billion)
28.3.1.13US Market Overview, By Payer Type, 2020–2034, Revenue (USD Billion)
28.3.1.14US Market Overview, By Care Setting, 2020–2034, Revenue (USD Billion)
28.3.1.15US Market Overview, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
28.3.2Canada
28.3.3Mexico
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 28.3.1 (US).
Chapter 29.Europe Home Infusion Therapy Market Deep-Dive, 2020–2034, Revenue (USD Billion)
29.1Overview, 2020–2034
29.2Size and Projections, 2020–2034, Revenue (USD Billion)
29.2.1By Therapy Type, 2020–2034
29.2.2By Product, 2020–2034
29.2.3By Service Type, 2020–2034
29.2.4By Route of Administration, 2020–2034
29.2.5By Indication, 2020–2034
29.2.6By Provider Type, 2020–2034
29.2.7By Patient Age Group, 2020–2034
29.2.8By Payer Type, 2020–2034
29.2.9By Care Setting, 2020–2034
29.2.10By Duration of Therapy, 2020–2034
29.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
29.3.1Germany
29.3.1.1Germany — Key Country Dynamics
29.3.1.2Germany — Regulatory Framework
29.3.1.3Germany — Competitive Scenario
29.3.1.4Germany — Market Overview, 2020–2034, Revenue (USD Billion)
29.3.1.5Germany — Market Size and Projections, 2020–2034, Revenue (USD Billion)
29.3.1.6Germany Market Overview, By Therapy Type, 2020–2034, Revenue (USD Billion)
29.3.1.7Germany Market Overview, By Product, 2020–2034, Revenue (USD Billion)
29.3.1.8Germany Market Overview, By Service Type, 2020–2034, Revenue (USD Billion)
29.3.1.9Germany Market Overview, By Route of Administration, 2020–2034, Revenue (USD Billion)
29.3.1.10Germany Market Overview, By Indication, 2020–2034, Revenue (USD Billion)
29.3.1.11Germany Market Overview, By Provider Type, 2020–2034, Revenue (USD Billion)
29.3.1.12Germany Market Overview, By Patient Age Group, 2020–2034, Revenue (USD Billion)
29.3.1.13Germany Market Overview, By Payer Type, 2020–2034, Revenue (USD Billion)
29.3.1.14Germany Market Overview, By Care Setting, 2020–2034, Revenue (USD Billion)
29.3.1.15Germany Market Overview, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
29.3.2France
29.3.3Italy
29.3.4Spain
29.3.5UK
29.3.6Nordic Countries
29.3.7Benelux Union
29.3.8Rest of Europe
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 29.3.1 (Germany).
Chapter 30.Asia Pacific Home Infusion Therapy Market Deep-Dive, 2020–2034, Revenue (USD Billion)
30.1Overview, 2020–2034
30.2Size and Projections, 2020–2034, Revenue (USD Billion)
30.2.1By Therapy Type, 2020–2034
30.2.2By Product, 2020–2034
30.2.3By Service Type, 2020–2034
30.2.4By Route of Administration, 2020–2034
30.2.5By Indication, 2020–2034
30.2.6By Provider Type, 2020–2034
30.2.7By Patient Age Group, 2020–2034
30.2.8By Payer Type, 2020–2034
30.2.9By Care Setting, 2020–2034
30.2.10By Duration of Therapy, 2020–2034
30.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
30.3.1India
30.3.1.1India — Key Country Dynamics
30.3.1.2India — Regulatory Framework
30.3.1.3India — Competitive Scenario
30.3.1.4India — Market Overview, 2020–2034, Revenue (USD Billion)
30.3.1.5India — Market Size and Projections, 2020–2034, Revenue (USD Billion)
30.3.1.6India Market Overview, By Therapy Type, 2020–2034, Revenue (USD Billion)
30.3.1.7India Market Overview, By Product, 2020–2034, Revenue (USD Billion)
30.3.1.8India Market Overview, By Service Type, 2020–2034, Revenue (USD Billion)
30.3.1.9India Market Overview, By Route of Administration, 2020–2034, Revenue (USD Billion)
30.3.1.10India Market Overview, By Indication, 2020–2034, Revenue (USD Billion)
30.3.1.11India Market Overview, By Provider Type, 2020–2034, Revenue (USD Billion)
30.3.1.12India Market Overview, By Patient Age Group, 2020–2034, Revenue (USD Billion)
30.3.1.13India Market Overview, By Payer Type, 2020–2034, Revenue (USD Billion)
30.3.1.14India Market Overview, By Care Setting, 2020–2034, Revenue (USD Billion)
30.3.1.15India Market Overview, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
30.3.2Australia
30.3.3China
30.3.4China (Taiwan)
30.3.5Japan
30.3.6South Korea
30.3.7Southeast Asia
30.3.8Indonesia
30.3.9Thailand
30.3.10Malaysia
30.3.11Singapore
30.3.12Rest of Asia Pacific
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 30.3.1 (India).
Chapter 31.Latin America Home Infusion Therapy Market Deep-Dive, 2020–2034, Revenue (USD Billion)
31.1Overview, 2020–2034
31.2Size and Projections, 2020–2034, Revenue (USD Billion)
31.2.1By Therapy Type, 2020–2034
31.2.2By Product, 2020–2034
31.2.3By Service Type, 2020–2034
31.2.4By Route of Administration, 2020–2034
31.2.5By Indication, 2020–2034
31.2.6By Provider Type, 2020–2034
31.2.7By Patient Age Group, 2020–2034
31.2.8By Payer Type, 2020–2034
31.2.9By Care Setting, 2020–2034
31.2.10By Duration of Therapy, 2020–2034
31.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
31.3.1Brazil
31.3.1.1Brazil — Key Country Dynamics
31.3.1.2Brazil — Regulatory Framework
31.3.1.3Brazil — Competitive Scenario
31.3.1.4Brazil — Market Overview, 2020–2034, Revenue (USD Billion)
31.3.1.5Brazil — Market Size and Projections, 2020–2034, Revenue (USD Billion)
31.3.1.6Brazil Market Overview, By Therapy Type, 2020–2034, Revenue (USD Billion)
31.3.1.7Brazil Market Overview, By Product, 2020–2034, Revenue (USD Billion)
31.3.1.8Brazil Market Overview, By Service Type, 2020–2034, Revenue (USD Billion)
31.3.1.9Brazil Market Overview, By Route of Administration, 2020–2034, Revenue (USD Billion)
31.3.1.10Brazil Market Overview, By Indication, 2020–2034, Revenue (USD Billion)
31.3.1.11Brazil Market Overview, By Provider Type, 2020–2034, Revenue (USD Billion)
31.3.1.12Brazil Market Overview, By Patient Age Group, 2020–2034, Revenue (USD Billion)
31.3.1.13Brazil Market Overview, By Payer Type, 2020–2034, Revenue (USD Billion)
31.3.1.14Brazil Market Overview, By Care Setting, 2020–2034, Revenue (USD Billion)
31.3.1.15Brazil Market Overview, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
31.3.2Argentina
31.3.3Rest of Latin America
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 31.3.1 (Brazil).
Chapter 32.Middle East and Africa Home Infusion Therapy Market Deep-Dive, 2020–2034, Revenue (USD Billion)
32.1Overview, 2020–2034
32.2Size and Projections, 2020–2034, Revenue (USD Billion)
32.2.1By Therapy Type, 2020–2034
32.2.2By Product, 2020–2034
32.2.3By Service Type, 2020–2034
32.2.4By Route of Administration, 2020–2034
32.2.5By Indication, 2020–2034
32.2.6By Provider Type, 2020–2034
32.2.7By Patient Age Group, 2020–2034
32.2.8By Payer Type, 2020–2034
32.2.9By Care Setting, 2020–2034
32.2.10By Duration of Therapy, 2020–2034
32.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
32.3.1GCC
32.3.1.1GCC — Key Country Dynamics
32.3.1.2GCC — Regulatory Framework
32.3.1.3GCC — Competitive Scenario
32.3.1.4GCC — Market Overview, 2020–2034, Revenue (USD Billion)
32.3.1.5GCC — Market Size and Projections, 2020–2034, Revenue (USD Billion)
32.3.1.6GCC Market Overview, By Therapy Type, 2020–2034, Revenue (USD Billion)
32.3.1.7GCC Market Overview, By Product, 2020–2034, Revenue (USD Billion)
32.3.1.8GCC Market Overview, By Service Type, 2020–2034, Revenue (USD Billion)
32.3.1.9GCC Market Overview, By Route of Administration, 2020–2034, Revenue (USD Billion)
32.3.1.10GCC Market Overview, By Indication, 2020–2034, Revenue (USD Billion)
32.3.1.11GCC Market Overview, By Provider Type, 2020–2034, Revenue (USD Billion)
32.3.1.12GCC Market Overview, By Patient Age Group, 2020–2034, Revenue (USD Billion)
32.3.1.13GCC Market Overview, By Payer Type, 2020–2034, Revenue (USD Billion)
32.3.1.14GCC Market Overview, By Care Setting, 2020–2034, Revenue (USD Billion)
32.3.1.15GCC Market Overview, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
32.3.2Egypt
32.3.3South Africa
32.3.4Rest of the Middle East & Africa
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 32.3.1 (GCC).
Chapter 33.Application / Use-Case Analysis
Chapter 34.Vendor Capability Scorecard
Chapter 35.Scenario Forecasts
35.1Bull-case Trajectory
35.2Base-case Trajectory
35.3Bear-case Trajectory
Chapter 36.Top 10 Key Clients of Top 10 Players
Chapter 37.Top 10 Suppliers
Chapter 38.Competitive Landscape
38.1Option Care Health, Inc.
38.2Optum Infusion Pharmacy (UnitedHealth Group Incorporated)
38.3Coram (CVS Health Corporation)
38.4BrightSpring Health Services, Inc.
38.5Amerita, Inc.
38.6KabaFusion
38.7Baxter International Inc.
38.8B. Braun Melsungen AG
38.9BD (Becton, Dickinson and Company)
38.10ICU Medical, Inc.
38.11Fresenius Kabi AG
38.12Soleo Health
38.13Triple Crown Infusion Services
38.14Vivo Infusion
38.15Premier Infusion Care
38.16Wellsky Corporation (CareCentrix)
38.17Avant Healthcare Professionals
38.18ARJ Infusion Services
38.19Eversana Life Science Services LLC
38.20Smiths Medical (ICU Medical)
38.21Moog Medical Devices Group
38.22Terumo Corporation
38.23Nipro Corporation
38.24Zyno Medical
38.25InfuSystem Holdings, Inc.
38.26Sanofi (Home infusion support)
38.27Takeda Pharmaceutical Company Limited
38.28CSL Behring (CSL Limited)
38.29Fresenius Kabi Home Care
38.30Medline Industries, LP
38.31Apria Healthcare Group
38.32Lincare Holdings Inc.
38.33Linde Healthcare Homecare
38.34Vitalaire (Air Liquide Santé)
38.35Orkla Care
Chapter 39.Partnerships & M&A
Chapter 40.Key Vendor Analysis
40.1Option Care Health, Inc.
40.2Optum Infusion Pharmacy (UnitedHealth Group Incorporated)
40.3Coram (CVS Health Corporation)
40.4BrightSpring Health Services, Inc.
40.5Amerita, Inc.
40.6KabaFusion
40.7Baxter International Inc.
40.8B. Braun Melsungen AG
40.9BD (Becton, Dickinson and Company)
40.10ICU Medical, Inc.
40.11Fresenius Kabi AG
40.12Soleo Health
40.13Triple Crown Infusion Services
40.14Vivo Infusion
40.15Premier Infusion Care
40.16Wellsky Corporation (CareCentrix)
40.17Avant Healthcare Professionals
40.18ARJ Infusion Services
40.19Eversana Life Science Services LLC
40.20Smiths Medical (ICU Medical)
40.21Moog Medical Devices Group
40.22Terumo Corporation
40.23Nipro Corporation
40.24Zyno Medical
40.25InfuSystem Holdings, Inc.
40.26Sanofi (Home infusion support)
40.27Takeda Pharmaceutical Company Limited
40.28CSL Behring (CSL Limited)
40.29Fresenius Kabi Home Care
40.30Medline Industries, LP
40.31Apria Healthcare Group
40.32Lincare Holdings Inc.
40.33Linde Healthcare Homecare
40.34Vitalaire (Air Liquide Santé)
40.35Orkla Care
Chapter 41.Marketing Strategy Analysis, Distributors & Traders
Chapter 42.Outlook of the Market
Chapter 43.Concluding Analyst Note
List of Figures+

Structural index generated from this report's own section headings, not verified against the delivered report's actual figure numbering.

Figure 2.1Top 3 Trends to Watch
Figure 2.4Top Investment Pockets
Figure 2.4.1Market Attractiveness Analysis, By Therapy Type
Figure 2.4.2Market Attractiveness Analysis, By Product
Figure 2.4.3Market Attractiveness Analysis, By Service Type
Figure 2.4.4Market Attractiveness Analysis, By Route of Administration
Figure 2.4.5Market Attractiveness Analysis, By Indication
Figure 2.4.6Market Attractiveness Analysis, By Provider Type
Figure 2.4.7Market Attractiveness Analysis, By Patient Age Group
Figure 2.4.8Market Attractiveness Analysis, By Payer Type
Figure 2.4.9Market Attractiveness Analysis, By Care Setting
Figure 2.4.10Market Attractiveness Analysis, By Duration of Therapy
Figure 2.5Key Market Participants — Intensity Mapping
Figure 4.2.2.2Data Triangulation
Figure 4.3Flow Of Methodology
Figure 4.4Top-Down / Bottom-Up Approach
Figure 6.1.2Product Differentiation and Positioning Logic
Figure 16.3Global Home Infusion Therapy Market Share, By Therapy Type (%)
Figure 17.3Global Home Infusion Therapy Market Share, By Product (%)
Figure 18.3Global Home Infusion Therapy Market Share, By Service Type (%)
Figure 19.3Global Home Infusion Therapy Market Share, By Route of Administration (%)
Figure 20.3Global Home Infusion Therapy Market Share, By Indication (%)
Figure 21.3Global Home Infusion Therapy Market Share, By Provider Type (%)
Figure 22.3Global Home Infusion Therapy Market Share, By Patient Age Group (%)
Figure 23.3Global Home Infusion Therapy Market Share, By Payer Type (%)
Figure 24.3Global Home Infusion Therapy Market Share, By Care Setting (%)
Figure 25.3Global Home Infusion Therapy Market Share, By Duration of Therapy (%)
Figure 27.2Share, By Geography, 2020–2034 (%)
Figure 27.3Share, By Geography Analysis, 2025, Market Share and CAGR
List of Tables+

Structural index generated from this report's own section headings, not verified against the delivered report's actual table numbering.

Table 1.3Home Infusion Therapy Comparison By Segments
Table 4.1.2Market Size Estimation
Table 15.1Global Home Infusion Therapy Market Size — Total
Table 15.2Market Size, by Segment (By Therapy Type, By Product, By Service Type, By Route of Administration, By Indication, By Provider Type, By Patient Age Group, By Payer Type, By Care Setting, By Duration of Therapy)
Table 16.2Global Home Infusion Therapy Market Size, By Therapy Type, 2020–2034, Revenue (USD Billion)
Table 16.3.1.1Market Size, By Anti-Infective Therapy, 2020–2034, Revenue (USD Billion)
Table 16.3.1.2Anti-Infective Therapy Size and Projections, By Product, 2020–2034, Revenue (USD Billion)
Table 16.3.1.3Anti-Infective Therapy Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
Table 16.3.1.4Anti-Infective Therapy Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 16.3.1.5Anti-Infective Therapy Size and Projections, By Indication, 2020–2034, Revenue (USD Billion)
Table 16.3.1.6Anti-Infective Therapy Size and Projections, By Provider Type, 2020–2034, Revenue (USD Billion)
Table 16.3.1.7Anti-Infective Therapy Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 16.3.1.8Anti-Infective Therapy Size and Projections, By Payer Type, 2020–2034, Revenue (USD Billion)
Table 16.3.1.9Anti-Infective Therapy Size and Projections, By Care Setting, 2020–2034, Revenue (USD Billion)
Table 16.3.1.10Anti-Infective Therapy Size and Projections, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
Table 17.2Global Home Infusion Therapy Market Size, By Product, 2020–2034, Revenue (USD Billion)
Table 17.3.1.1Market Size, By Infusion Pumps, 2020–2034, Revenue (USD Billion)
Table 17.3.1.2Infusion Pumps Size and Projections, By Therapy Type, 2020–2034, Revenue (USD Billion)
Table 17.3.1.3Infusion Pumps Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
Table 17.3.1.4Infusion Pumps Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 17.3.1.5Infusion Pumps Size and Projections, By Indication, 2020–2034, Revenue (USD Billion)
Table 17.3.1.6Infusion Pumps Size and Projections, By Provider Type, 2020–2034, Revenue (USD Billion)
Table 17.3.1.7Infusion Pumps Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 17.3.1.8Infusion Pumps Size and Projections, By Payer Type, 2020–2034, Revenue (USD Billion)
Table 17.3.1.9Infusion Pumps Size and Projections, By Care Setting, 2020–2034, Revenue (USD Billion)
Table 17.3.1.10Infusion Pumps Size and Projections, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
Table 18.2Global Home Infusion Therapy Market Size, By Service Type, 2020–2034, Revenue (USD Billion)
Table 18.3.1.1Market Size, By Pharmacy Compounding and Dispensing, 2020–2034, Revenue (USD Billion)
Table 18.3.1.2Pharmacy Compounding and Dispensing Size and Projections, By Therapy Type, 2020–2034, Revenue (USD Billion)
Table 18.3.1.3Pharmacy Compounding and Dispensing Size and Projections, By Product, 2020–2034, Revenue (USD Billion)
Table 18.3.1.4Pharmacy Compounding and Dispensing Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 18.3.1.5Pharmacy Compounding and Dispensing Size and Projections, By Indication, 2020–2034, Revenue (USD Billion)
Table 18.3.1.6Pharmacy Compounding and Dispensing Size and Projections, By Provider Type, 2020–2034, Revenue (USD Billion)
Table 18.3.1.7Pharmacy Compounding and Dispensing Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 18.3.1.8Pharmacy Compounding and Dispensing Size and Projections, By Payer Type, 2020–2034, Revenue (USD Billion)
Table 18.3.1.9Pharmacy Compounding and Dispensing Size and Projections, By Care Setting, 2020–2034, Revenue (USD Billion)
Table 18.3.1.10Pharmacy Compounding and Dispensing Size and Projections, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
Table 19.2Global Home Infusion Therapy Market Size, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 19.3.1.1Market Size, By Intravenous, 2020–2034, Revenue (USD Billion)
Table 19.3.1.2Intravenous Size and Projections, By Therapy Type, 2020–2034, Revenue (USD Billion)
Table 19.3.1.3Intravenous Size and Projections, By Product, 2020–2034, Revenue (USD Billion)
Table 19.3.1.4Intravenous Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
Table 19.3.1.5Intravenous Size and Projections, By Indication, 2020–2034, Revenue (USD Billion)
Table 19.3.1.6Intravenous Size and Projections, By Provider Type, 2020–2034, Revenue (USD Billion)
Table 19.3.1.7Intravenous Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 19.3.1.8Intravenous Size and Projections, By Payer Type, 2020–2034, Revenue (USD Billion)
Table 19.3.1.9Intravenous Size and Projections, By Care Setting, 2020–2034, Revenue (USD Billion)
Table 19.3.1.10Intravenous Size and Projections, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
Table 20.2Global Home Infusion Therapy Market Size, By Indication, 2020–2034, Revenue (USD Billion)
Table 20.3.1.1Market Size, By Infectious Diseases, 2020–2034, Revenue (USD Billion)
Table 20.3.1.2Infectious Diseases Size and Projections, By Therapy Type, 2020–2034, Revenue (USD Billion)
Table 20.3.1.3Infectious Diseases Size and Projections, By Product, 2020–2034, Revenue (USD Billion)
Table 20.3.1.4Infectious Diseases Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
Table 20.3.1.5Infectious Diseases Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 20.3.1.6Infectious Diseases Size and Projections, By Provider Type, 2020–2034, Revenue (USD Billion)
Table 20.3.1.7Infectious Diseases Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 20.3.1.8Infectious Diseases Size and Projections, By Payer Type, 2020–2034, Revenue (USD Billion)
Table 20.3.1.9Infectious Diseases Size and Projections, By Care Setting, 2020–2034, Revenue (USD Billion)
Table 20.3.1.10Infectious Diseases Size and Projections, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
Table 21.2Global Home Infusion Therapy Market Size, By Provider Type, 2020–2034, Revenue (USD Billion)
Table 21.3.1.1Market Size, By Independent Home Infusion Pharmacies, 2020–2034, Revenue (USD Billion)
Table 21.3.1.2Independent Home Infusion Pharmacies Size and Projections, By Therapy Type, 2020–2034, Revenue (USD Billion)
Table 21.3.1.3Independent Home Infusion Pharmacies Size and Projections, By Product, 2020–2034, Revenue (USD Billion)
Table 21.3.1.4Independent Home Infusion Pharmacies Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
Table 21.3.1.5Independent Home Infusion Pharmacies Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 21.3.1.6Independent Home Infusion Pharmacies Size and Projections, By Indication, 2020–2034, Revenue (USD Billion)
Table 21.3.1.7Independent Home Infusion Pharmacies Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 21.3.1.8Independent Home Infusion Pharmacies Size and Projections, By Payer Type, 2020–2034, Revenue (USD Billion)
Table 21.3.1.9Independent Home Infusion Pharmacies Size and Projections, By Care Setting, 2020–2034, Revenue (USD Billion)
Table 21.3.1.10Independent Home Infusion Pharmacies Size and Projections, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
Table 22.2Global Home Infusion Therapy Market Size, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 22.3.1.1Market Size, By Pediatric, 2020–2034, Revenue (USD Billion)
Table 22.3.1.2Pediatric Size and Projections, By Therapy Type, 2020–2034, Revenue (USD Billion)
Table 22.3.1.3Pediatric Size and Projections, By Product, 2020–2034, Revenue (USD Billion)
Table 22.3.1.4Pediatric Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
Table 22.3.1.5Pediatric Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 22.3.1.6Pediatric Size and Projections, By Indication, 2020–2034, Revenue (USD Billion)
Table 22.3.1.7Pediatric Size and Projections, By Provider Type, 2020–2034, Revenue (USD Billion)
Table 22.3.1.8Pediatric Size and Projections, By Payer Type, 2020–2034, Revenue (USD Billion)
Table 22.3.1.9Pediatric Size and Projections, By Care Setting, 2020–2034, Revenue (USD Billion)
Table 22.3.1.10Pediatric Size and Projections, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
Table 23.2Global Home Infusion Therapy Market Size, By Payer Type, 2020–2034, Revenue (USD Billion)
Table 23.3.1.1Market Size, By Medicare, 2020–2034, Revenue (USD Billion)
Table 23.3.1.2Medicare Size and Projections, By Therapy Type, 2020–2034, Revenue (USD Billion)
Table 23.3.1.3Medicare Size and Projections, By Product, 2020–2034, Revenue (USD Billion)
Table 23.3.1.4Medicare Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
Table 23.3.1.5Medicare Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 23.3.1.6Medicare Size and Projections, By Indication, 2020–2034, Revenue (USD Billion)
Table 23.3.1.7Medicare Size and Projections, By Provider Type, 2020–2034, Revenue (USD Billion)
Table 23.3.1.8Medicare Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 23.3.1.9Medicare Size and Projections, By Care Setting, 2020–2034, Revenue (USD Billion)
Table 23.3.1.10Medicare Size and Projections, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
Table 24.2Global Home Infusion Therapy Market Size, By Care Setting, 2020–2034, Revenue (USD Billion)
Table 24.3.1.1Market Size, By Patient Home, 2020–2034, Revenue (USD Billion)
Table 24.3.1.2Patient Home Size and Projections, By Therapy Type, 2020–2034, Revenue (USD Billion)
Table 24.3.1.3Patient Home Size and Projections, By Product, 2020–2034, Revenue (USD Billion)
Table 24.3.1.4Patient Home Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
Table 24.3.1.5Patient Home Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 24.3.1.6Patient Home Size and Projections, By Indication, 2020–2034, Revenue (USD Billion)
Table 24.3.1.7Patient Home Size and Projections, By Provider Type, 2020–2034, Revenue (USD Billion)
Table 24.3.1.8Patient Home Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 24.3.1.9Patient Home Size and Projections, By Payer Type, 2020–2034, Revenue (USD Billion)
Table 24.3.1.10Patient Home Size and Projections, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
Table 25.2Global Home Infusion Therapy Market Size, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
Table 25.3.1.1Market Size, By Short-Term (Acute) Therapy, 2020–2034, Revenue (USD Billion)
Table 25.3.1.2Short-Term (Acute) Therapy Size and Projections, By Therapy Type, 2020–2034, Revenue (USD Billion)
Table 25.3.1.3Short-Term (Acute) Therapy Size and Projections, By Product, 2020–2034, Revenue (USD Billion)
Table 25.3.1.4Short-Term (Acute) Therapy Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
Table 25.3.1.5Short-Term (Acute) Therapy Size and Projections, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 25.3.1.6Short-Term (Acute) Therapy Size and Projections, By Indication, 2020–2034, Revenue (USD Billion)
Table 25.3.1.7Short-Term (Acute) Therapy Size and Projections, By Provider Type, 2020–2034, Revenue (USD Billion)
Table 25.3.1.8Short-Term (Acute) Therapy Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 25.3.1.9Short-Term (Acute) Therapy Size and Projections, By Payer Type, 2020–2034, Revenue (USD Billion)
Table 25.3.1.10Short-Term (Acute) Therapy Size and Projections, By Care Setting, 2020–2034, Revenue (USD Billion)
Table 27.1Revenue, By Geography, 2020–2034, Revenue (USD Billion)
Table 27.4Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 28.1Overview, 2020–2034
Table 28.2Size and Projections, 2020–2034, Revenue (USD Billion)
Table 28.2.1By Therapy Type, 2020–2034
Table 28.2.2By Product, 2020–2034
Table 28.2.3By Service Type, 2020–2034
Table 28.2.4By Route of Administration, 2020–2034
Table 28.2.5By Indication, 2020–2034
Table 28.2.6By Provider Type, 2020–2034
Table 28.2.7By Patient Age Group, 2020–2034
Table 28.2.8By Payer Type, 2020–2034
Table 28.2.9By Care Setting, 2020–2034
Table 28.2.10By Duration of Therapy, 2020–2034
Table 28.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 28.3.1.4US — Market Overview, 2020–2034, Revenue (USD Billion)
Table 28.3.1.5US — Market Size and Projections, 2020–2034, Revenue (USD Billion)
Table 28.3.1.6US Market Overview, By Therapy Type, 2020–2034, Revenue (USD Billion)
Table 28.3.1.7US Market Overview, By Product, 2020–2034, Revenue (USD Billion)
Table 28.3.1.8US Market Overview, By Service Type, 2020–2034, Revenue (USD Billion)
Table 28.3.1.9US Market Overview, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 28.3.1.10US Market Overview, By Indication, 2020–2034, Revenue (USD Billion)
Table 28.3.1.11US Market Overview, By Provider Type, 2020–2034, Revenue (USD Billion)
Table 28.3.1.12US Market Overview, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 28.3.1.13US Market Overview, By Payer Type, 2020–2034, Revenue (USD Billion)
Table 28.3.1.14US Market Overview, By Care Setting, 2020–2034, Revenue (USD Billion)
Table 28.3.1.15US Market Overview, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
Table 29.1Overview, 2020–2034
Table 29.2Size and Projections, 2020–2034, Revenue (USD Billion)
Table 29.2.1By Therapy Type, 2020–2034
Table 29.2.2By Product, 2020–2034
Table 29.2.3By Service Type, 2020–2034
Table 29.2.4By Route of Administration, 2020–2034
Table 29.2.5By Indication, 2020–2034
Table 29.2.6By Provider Type, 2020–2034
Table 29.2.7By Patient Age Group, 2020–2034
Table 29.2.8By Payer Type, 2020–2034
Table 29.2.9By Care Setting, 2020–2034
Table 29.2.10By Duration of Therapy, 2020–2034
Table 29.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 29.3.1.4Germany — Market Overview, 2020–2034, Revenue (USD Billion)
Table 29.3.1.5Germany — Market Size and Projections, 2020–2034, Revenue (USD Billion)
Table 29.3.1.6Germany Market Overview, By Therapy Type, 2020–2034, Revenue (USD Billion)
Table 29.3.1.7Germany Market Overview, By Product, 2020–2034, Revenue (USD Billion)
Table 29.3.1.8Germany Market Overview, By Service Type, 2020–2034, Revenue (USD Billion)
Table 29.3.1.9Germany Market Overview, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 29.3.1.10Germany Market Overview, By Indication, 2020–2034, Revenue (USD Billion)
Table 29.3.1.11Germany Market Overview, By Provider Type, 2020–2034, Revenue (USD Billion)
Table 29.3.1.12Germany Market Overview, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 29.3.1.13Germany Market Overview, By Payer Type, 2020–2034, Revenue (USD Billion)
Table 29.3.1.14Germany Market Overview, By Care Setting, 2020–2034, Revenue (USD Billion)
Table 29.3.1.15Germany Market Overview, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
Table 30.1Overview, 2020–2034
Table 30.2Size and Projections, 2020–2034, Revenue (USD Billion)
Table 30.2.1By Therapy Type, 2020–2034
Table 30.2.2By Product, 2020–2034
Table 30.2.3By Service Type, 2020–2034
Table 30.2.4By Route of Administration, 2020–2034
Table 30.2.5By Indication, 2020–2034
Table 30.2.6By Provider Type, 2020–2034
Table 30.2.7By Patient Age Group, 2020–2034
Table 30.2.8By Payer Type, 2020–2034
Table 30.2.9By Care Setting, 2020–2034
Table 30.2.10By Duration of Therapy, 2020–2034
Table 30.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 30.3.1.4India — Market Overview, 2020–2034, Revenue (USD Billion)
Table 30.3.1.5India — Market Size and Projections, 2020–2034, Revenue (USD Billion)
Table 30.3.1.6India Market Overview, By Therapy Type, 2020–2034, Revenue (USD Billion)
Table 30.3.1.7India Market Overview, By Product, 2020–2034, Revenue (USD Billion)
Table 30.3.1.8India Market Overview, By Service Type, 2020–2034, Revenue (USD Billion)
Table 30.3.1.9India Market Overview, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 30.3.1.10India Market Overview, By Indication, 2020–2034, Revenue (USD Billion)
Table 30.3.1.11India Market Overview, By Provider Type, 2020–2034, Revenue (USD Billion)
Table 30.3.1.12India Market Overview, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 30.3.1.13India Market Overview, By Payer Type, 2020–2034, Revenue (USD Billion)
Table 30.3.1.14India Market Overview, By Care Setting, 2020–2034, Revenue (USD Billion)
Table 30.3.1.15India Market Overview, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
Table 31.1Overview, 2020–2034
Table 31.2Size and Projections, 2020–2034, Revenue (USD Billion)
Table 31.2.1By Therapy Type, 2020–2034
Table 31.2.2By Product, 2020–2034
Table 31.2.3By Service Type, 2020–2034
Table 31.2.4By Route of Administration, 2020–2034
Table 31.2.5By Indication, 2020–2034
Table 31.2.6By Provider Type, 2020–2034
Table 31.2.7By Patient Age Group, 2020–2034
Table 31.2.8By Payer Type, 2020–2034
Table 31.2.9By Care Setting, 2020–2034
Table 31.2.10By Duration of Therapy, 2020–2034
Table 31.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 31.3.1.4Brazil — Market Overview, 2020–2034, Revenue (USD Billion)
Table 31.3.1.5Brazil — Market Size and Projections, 2020–2034, Revenue (USD Billion)
Table 31.3.1.6Brazil Market Overview, By Therapy Type, 2020–2034, Revenue (USD Billion)
Table 31.3.1.7Brazil Market Overview, By Product, 2020–2034, Revenue (USD Billion)
Table 31.3.1.8Brazil Market Overview, By Service Type, 2020–2034, Revenue (USD Billion)
Table 31.3.1.9Brazil Market Overview, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 31.3.1.10Brazil Market Overview, By Indication, 2020–2034, Revenue (USD Billion)
Table 31.3.1.11Brazil Market Overview, By Provider Type, 2020–2034, Revenue (USD Billion)
Table 31.3.1.12Brazil Market Overview, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 31.3.1.13Brazil Market Overview, By Payer Type, 2020–2034, Revenue (USD Billion)
Table 31.3.1.14Brazil Market Overview, By Care Setting, 2020–2034, Revenue (USD Billion)
Table 31.3.1.15Brazil Market Overview, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
Table 32.1Overview, 2020–2034
Table 32.2Size and Projections, 2020–2034, Revenue (USD Billion)
Table 32.2.1By Therapy Type, 2020–2034
Table 32.2.2By Product, 2020–2034
Table 32.2.3By Service Type, 2020–2034
Table 32.2.4By Route of Administration, 2020–2034
Table 32.2.5By Indication, 2020–2034
Table 32.2.6By Provider Type, 2020–2034
Table 32.2.7By Patient Age Group, 2020–2034
Table 32.2.8By Payer Type, 2020–2034
Table 32.2.9By Care Setting, 2020–2034
Table 32.2.10By Duration of Therapy, 2020–2034
Table 32.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 32.3.1.4GCC — Market Overview, 2020–2034, Revenue (USD Billion)
Table 32.3.1.5GCC — Market Size and Projections, 2020–2034, Revenue (USD Billion)
Table 32.3.1.6GCC Market Overview, By Therapy Type, 2020–2034, Revenue (USD Billion)
Table 32.3.1.7GCC Market Overview, By Product, 2020–2034, Revenue (USD Billion)
Table 32.3.1.8GCC Market Overview, By Service Type, 2020–2034, Revenue (USD Billion)
Table 32.3.1.9GCC Market Overview, By Route of Administration, 2020–2034, Revenue (USD Billion)
Table 32.3.1.10GCC Market Overview, By Indication, 2020–2034, Revenue (USD Billion)
Table 32.3.1.11GCC Market Overview, By Provider Type, 2020–2034, Revenue (USD Billion)
Table 32.3.1.12GCC Market Overview, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 32.3.1.13GCC Market Overview, By Payer Type, 2020–2034, Revenue (USD Billion)
Table 32.3.1.14GCC Market Overview, By Care Setting, 2020–2034, Revenue (USD Billion)
Table 32.3.1.15GCC Market Overview, By Duration of Therapy, 2020–2034, Revenue (USD Billion)
Scope

Questions This Report Answers

6 questions
01

What is the market size and growth rate, globally and by region?

02

How is the market segmented, and which segments lead?

03

Which regions and countries are covered, and how do they compare?

04

What are the key drivers, restraints, opportunities and challenges?

05

Who are the leading companies operating in this market?

06

What trends are expected to shape the market through the forecast period?

Questions

Frequently Asked Questions

01What is the Home Infusion Therapy Market projected to reach?

USD 82.96 USD Billion by 2034, CAGR 8%

02What years does this report cover?

Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.

03Which regions are covered?

North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

04Which segment leads the market?

Anti-Infective Therapy is the largest line by therapy type, at 26.99% of revenue in 2025.

05Who are the key companies profiled?

Option Care Health, Inc., Optum Infusion Pharmacy (UnitedHealth Group Incorporated), Coram (CVS Health Corporation), BrightSpring Health Services, Inc., Amerita, Inc., KabaFusion, Baxter International Inc., B. Braun Melsungen AG, BD (Becton, Dickinson and Company), ICU Medical, Inc., Fresenius Kabi AG, Soleo Health, Triple Crown Infusion Services, Vivo Infusion, Premier Infusion Care, Wellsky Corporation (CareCentrix), Avant Healthcare Professionals, ARJ Infusion Services, Eversana Life Science Services LLC, Smiths Medical (ICU Medical), Moog Medical Devices Group, Terumo Corporation, Nipro Corporation, Zyno Medical, InfuSystem Holdings, Inc., Sanofi (Home infusion support), Takeda Pharmaceutical Company Limited, CSL Behring (CSL Limited), Fresenius Kabi Home Care, Medline Industries, LP, Apria Healthcare Group, Lincare Holdings Inc., Linde Healthcare Homecare, Vitalaire (Air Liquide Santé), Orkla Care. Full profiles are part of the paid report.

06Can the segmentation be customized?

Yes. Custom data cuts by geography, segment, or competitor set are available on request.

425+
Dedicated research analysts
1,200+
Reports published
Why CDI

Why choose CDI

Data triangulated across primary and secondary sources
Complimentary analyst call included with every purchase
Custom data cuts and post-purchase support available

Need this report shaped around your question?

The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.

Most licences include 30–60 hours of customization at no extra cost. See what each licence includes

Request customization

Additional Companies

Add competitors, suppliers or the peer set you benchmark against to the companies already covered.

Deeper Competitive View

Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.

Extra Segment Splits

Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.

Application Focus

Narrow the analysis to the specific use cases and end users your team actually sells into.

Different Time Frame

Move the base year, or widen the historical and forecast windows the study is built on.

Country-Level Detail

Go below region level into the individual countries that matter to you, rather than the standard geography split.